A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Moderna plans to advance research on the mRNA ... which it plans to present at a scientific conference in the near future. “Avian flu variants have proven to be particularly unpredictable ...